PembROlizuMab Immunotherapy Versus Standard Chemotherapy for Advanced prE-treated Malignant Pleural Mesothelioma
- Status
- COMPLETED
- Phase
- PHASE3
Clinical Trials Related to Merck Sharp & Dohme LLC
Related studies linked through entity extraction aliases.
Pembrolizumab and Exemestane/ Leuprolide in Premenopausal HR+/ HER2- Locally Advanced or Metastatic Breast Cancer
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
A Study to Evaluate the Safety, Tolerability, and Immunogenicity of Two Lots of V114 in Healthy Infants (V114-008)
- Status
- COMPLETED
- Phase
- PHASE2
Study of Olaparib (Lynparza™) Versus Enzalutamide or Abiraterone Acetate in Men With Metastatic Castration-Resistant Prostate Cancer (PROfound Study)
- Status
- COMPLETED
- Phase
- PHASE3
Evaluating Combination Immunotherapy for Advanced Cholangiocarcinoma With Pembrolizumab and PEG-Intron
- Status
- TERMINATED
- Phase
- PHASE2
Study of GVAX (With CY) and Pembrolizumab in MMR-p Advanced Colorectal Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Study of Imprime PGG and Pembrolizumab in Advanced Melanoma and Triple Negative Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Phase I/II Study of U3-1402 in Subjects With Human Epidermal Growth Factor Receptor 3 (HER3) Positive Metastatic Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Effects of MK-3475 (Pembrolizumab) on the Breast Tumor Microenvironment in Triple Negative Breast Cancer
- Status
- RECRUITING
- Phase
- PHASE1
Vorapaxar and Lower Extremity Bypass Grafts
- Status
- WITHDRAWN
- Phase
- PHASE4
Study to Investigate the Efficacy of Elbasvir/Grazoprevir Fixed-Dose Combination for 8 Weeks in Treatment-Naïve, HCV GT1b-Infected Patients, With Non-severe Fibrosis
- Status
- COMPLETED
- Phase
- PHASE3
Study of MK-8353 in Combination With Pembrolizumab (MK-3475) in Participants With Advanced Malignancies (MK-8353-013)
- Status
- TERMINATED
- Phase
- PHASE1
Pembrolizumab in Refractory Advanced Esophageal Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Pembrolizumab in Patients With Locally Advanced or Metastatic Skin Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Interleukin-2 and Pembrolizumab for Metastatic Kidney Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Study of Vibostolimab Alone and in Combination With Pembrolizumab in Advanced Solid Tumors (MK-7684-001) ( KEYVIBE-001)
- Status
- COMPLETED
- Phase
- PHASE1
Phase I/II Study of Lenalidomide Plus Pembrolizumab in Patients With Solid Tumors With Expansion in Non-small Cell Lung Cancer
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Pembrolizumab vs Topotecan in Patients With Small Cell Lung Cancer
- Status
- TERMINATED
- Phase
- PHASE2
Assessment of Immunogenicity of Zostavax® in Patients With Antibody Deficiency 60 Years of Age and Older
- Status
- TERMINATED
- Phase
- NA
Neoadjuvant Pembrolizumab + Decitabine Followed by Std Neoadj Chemo for Locally Advanced HER2- Breast Ca
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2